Press release
Urinary Tract Infection Treatment Market to Reach US$ 10 Billion Globally by 2022
New York, March 21: Market Research Engine has published a new report titled as “Urinary Tract Infection Treatment Market: Global Industry Analysis and Forecast 2016 – 2022”How Big is the Global Urinary Tract Infection Treatment Market?
The global urinary tract infection treatment market is expected to exceed more than US$ 10 Billion by 2022; Growing at a CAGR of more than 2% in the given forecast period.
Browse Full Report: https://www.marketresearchengine.com/reportdetails/urinary-tract-infection-treatment-market
Urinary tract infection (UTI) arises in the kidneys, ureter, urethra and bladder because of microbial pathogens in these parts. Urinary tract infections will be uncomplicated or complicated depends on the severity of infection. The penicillin antibiotic that is amoxicillin is used to treat urinary tract infections and it is mainly used as prescribed antibiotic for uncomplicated urinary tract infection. UTI is common bacterial infections affecting many of peoples globally. Continuing urinary tract infection is a main health problem in females worldwide. Patients with spinal cord injury or urinary catheter are mainly contract complicated urinary tract infections.
The urinary tract infection treatment market is segmented on the lines of its drug type, indication, distribution channel and regional. Based on drug type segmentation it covers sulphonamides, azoles and amphotericin B, tetracycline, nitrofurans, aminoglycoside antibiotics, cephalosporin, quinolones and penicillin & combinations. Aminoglycoside antibiotics is further segmented into amikacin and gentamicin. Cephalosporin segmentation covers ceftriaxone, cefuroxime, cefixime and cephalexin. Under quinolones segmentation it covers ciprofloxacin, levofloxacin, nalidixic acid, norfloxacin and others. Penicillin and combinations covers amoxicillin, amoxicillin & clavulanate potassium and others.
The urinary tract infection treatment market is segmented on the lines of its indication like into complicated UTI, recurring complicated UTI, uncomplicated UTI and neurogenic bladder infections. Under distribution channel segmentation it covers hospital pharmacies, gynaecology and urology clinics, drug store, retail pharmacies and online drug stores. The urinary tract infection treatment market’s geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for urinary tract infection treatment and related technologies.
2) Analysis of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for urinary tract infection treatment.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Download Free Sample Report: https://www.marketresearchengine.com/requestsample/urinary-tract-infection-treatment-market
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Urinary Tract Infection Treatment Market for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Johnson and Johnsons Private Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., Bayer AG, GlaxoSmithKline Pharmaceuticals Ltd., Pfizer Inc., F.Hoffmann-La Roche Ltd., Novartis AG. and AstraZeneca plc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Urinary Tract Infection Treatment Market has been segmented as below:
By Drug Type Analysis
• Sulphonamides
• Azoles and Amphotericin B
• Tetracycline
• Nitrofurans
• Aminoglycoside antibiotics
o Amikacin
o Gentamicin
• Cephalosporin
Ceftriaxone
Cefuroxime
Cefixime
Cephalexin
• Quinolones
Ciprofloxacin
Levofloxacin
Nalidixic acid
Norfloxacin
Others
• Penicillin & Combinations
Amoxicillin
Amoxicillin & Clavulanate Potassium
Others
By Indication Analysis
• Complicated UTI
• Recurring Complicated UTI
• Uncomplicated UTI
• Neurogenic Bladder Infections
By Distribution channel Analysis
• Hospital Pharmacies
• Gynaecology and Urology Clinics
• Drug Store
• Retail Pharmacies
• Online Drug Stores
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all urinary tract infection treatment .
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of urinary tract infection treatment data.
4) Assess your competitor’s refining portfolio and its evolution.
About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: https://www.marketresearchengine.com/
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Urinary Tract Infection Treatment Market to Reach US$ 10 Billion Globally by 2022 here
News-ID: 476831 • Views: …
More Releases from MRE Research
Orthopedic Devices Market is Expected to Reach US $47.50 Billion Globally by 202 …
The worldwide orthopedic devices market is in this way extensively sectioned into hip, knee, shoulder, elbow, foot and lower leg, spine, cranio-maxillofacial and different limits. These anatomical areas are further ordered into joint inserts, interior obsession gadgets and outer obsession gadgets, in view of the accessibility of the orthopedic gadgets items in the business sector. Geologically, the orthopedic gadgets business sector is dissected for four noteworthy locales, to be specific…
Live Cell Imaging Market is Expected to Reach US$ 8.5 Billion Globally by 2023
Rising need of live cell imaging going to increasing index of cancer victims is triggering the growth of the market. Its use in drug discovery is growth factor. High cost of imaging equipment is restraining factor for this market. It requires a skilled professional with immense knowledge for imaging and studying the live cells which is restraining factor.
The global live cell imaging market by product equipment, consumables and software. According…
Endocrine Testing Market is Expected to Cross US$ 13 Billion Globally By 2023
The Endocrine Testing market is segmented on the lines of its Test, Diagnostic technology, End User. The Endocrine Testing market is segmented on the lines of its Test type like Follicle stimulating hormone(FSH) Human Chorionic Gonadotropin (hCG) Thyroid stimulating Hormone(TSH) Dehydroepiandrosterone sulfate (DHEAS) Prolactin Progesterone Insulin Cortisol Testosterone Estradiol(E2) Luteinizing Hormone (LH). The Endocrine Testing market is segmented on the lines of its Diagnostic Technology as Immunoassay Clinical Chemistry…
Waterproofing Chemicals Market is Expected to Reach US$ 12,300.0 Million by Glob …
The demand for waterproofing chemicals has been moderate since the previous few years attributable to sluggish growth of key end-use industries, weak economic process, low shopper awareness in mass markets, and volatile stuff costs. The world consumption of Waterproofing Chemicals is but calculable to extend at a good rate throughout the forecast amount attributable to growth and investment activities in finish use trade.
Browse Full Report Here: https://www.marketresearchengine.com/reportdetails/waterproofing-chemicals-market-report
How Big is…
More Releases for UTI
Urinary Tract Infection (UTI) Treatment Market Expanding Solutions for Rising Gl …
Introduction
The urinary tract infection (UTI) treatment market is witnessing significant growth, driven by the increasing prevalence of UTIs globally, rising awareness of treatment options, and advances in medical technologies. UTIs affect millions of individuals each year, with women being disproportionately impacted. As antibiotic resistance becomes an increasing concern and healthcare providers explore alternative solutions, the market for UTI treatments continues to evolve.
This article explores the key factors driving the…
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Growing Demand for …
Introduction
Urinary tract infections (UTIs) are among the most common bacterial infections affecting individuals worldwide, especially women. They occur when harmful bacteria enter the urinary tract, leading to inflammation and discomfort. While most UTIs are uncomplicated, meaning they are limited to the lower urinary tract (bladder and urethra), their frequency and impact on daily life highlight the importance of effective treatments. The UTI treatment market is experiencing significant growth, driven by…
Retail Logistics Market Worth Observing Growth | Panalpina, Exel, UTi Worldwide
The latest launched report on Global Retail Logistics Market delivers a transformation framework to understand how megatrends affect industry growth, taking into account the major disrupting forces creating uncertainties for every organisation in the Retail Logistics. Based on these outcomes, HTF MI outline plan for these volatile scenarios considering companies such as APL Logistics, Schneider National, Maersk Logistics, SembCorp Logistics (USA), Panalpina, Exel, UTi Worldwide, Kuehne + Nagel International, DHL…
Investigation for Investors in shares of Patterson-UTI Energy, Inc. (NASDAQ: PTE …
An investigation was announced concnering potential breaches of fiduciary duties by certain directors at Patterson-UTI Energy, Inc.
Investors who purchased shares of Patterson-UTI Energy, Inc. (NASDAQ: PTEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Patterson-UTI Energy directors breached their fiduciary duties and caused damage to the company and its shareholders.
Houston, TX based Patterson-UTI…
UTI Treatment Market Therapeutic Assessment 2018-2023
Global and Chinese UTI Treatment Industry, 2018 Market Research Report:
The 'Global and Chinese UTI Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global UTI Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the UTI Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals…
Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally
Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract…
